Table of Contents

Table of Contents

Preface

Chapter 1. Overactive Bladder (OAB): Pathophysiology Epidemiology, and Treatment Options
Bárbara Padilla-Fernández, David Hernández-Hernández, Ruth Doherty, and David Castro-Díaz (Department of Urology, University Hospital of the Canary Islands, Tenerife, Spain, and others)

Chapter 2. The Epidemiology of Lower Urinary Tract Symptoms and Urinary Incontinence: A Critical Review of the Literature
Megan Solomon, Bertha Chen and Lisa Rogo-Gupta (Stanford University School of Medicine, Stanford, California, USA, and others)

Chapter 3. Overactive Bladder in the Pediatric Population
Sophie Ramsay, Anne-Sophie Blais, Geneviève Nadeau, Katherine Moore, and Stéphane Bolduc (Division of Urology, CHU de Québec-Université Laval, Québec, Canada)

Chapter 4. Current Updates on Overactive Bladder Management
Kirin K. Syed and Angelo E. Gousse (Bladder Health and Reconstructive Urology Institute, Miramar, FL, USA)

Chapter 5. Investigational and Promising Novel Therapeutics for the Overactive Bladder and Urgency Urinary Incontinence
Emilio Sacco and Riccardo Bientinesi (Urology Department, “Agostino Gemelli” Academic Hospital, Catholic University of Sacred Heart, Rome, Italy)

Chapter 6. Overactive Bladder (OAB): Is There a Place for Drugs Targeting the Purinergic Cascade?
M. Silva-Ramos, I. Silva, F. Ferreirinha, M. Faria, and P. Correia-de-Sá (Laboratório de Farmacologia e Neurobiologia, Center for Drug Discovery and Innovative Medicines (MedInUP), Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto, Serviço de Urologia, Centro Hospitalar do Porto (CHP), Porto, Portugal)

Chapter 7. Mirabegron for the Treatment of Overactive Bladder
Federica Laraud, Simone Ferrero and Umberto Leone Roberti Maggiore (Academic Unit of Obstetrics and Gynaecology, IRCCS AOU San Martino – IST, Genoa, Italy, and others)

Index